FDA expresses concerns about the promotion and marketing of electronic nicotine delivery systems
The Food and Drug Administration (FDA) has issued a warning against the marketing, sale, and use of Electronic Delivery Systems (ENDS), such as vapes and other non-nicotine tobacco products, for amusement. The FDA voiced concerns on the abuse of these products in a statement dated July 5 and highlighted the possible health hazards, including cancer,…

The Food and Drug Administration (FDA) has issued a warning against the marketing, sale, and use of Electronic Delivery Systems (ENDS), such as vapes and other non-nicotine tobacco products, for amusement.
The FDA voiced concerns on the abuse of these products in a statement dated July 5 and highlighted the possible health hazards, including cancer, lung illness, infertility, heart disease, and diabetes.
The prospect of certifying ENDS as a prescription-only drug for cessation therapy is also mentioned in the statement.
The FDA voiced concerns on the abuse of these products in a statement dated July 5 and highlighted the possible health hazards, including cancer, lung illness, infertility, heart disease, and diabetes.
The prospect of certifying ENDS as a prescription-only drug for cessation therapy is also mentioned in the statement.
The FDA said in its statement that ENDS can be registered as a medication that is exclusively available with a prescription for use in cessation therapy.
The sale, promotion, and recreational use of electronic nicotine delivery systems (ENDS) like vapes and other non-nicotine tobacco products by the general population have been recognised by the Food and Drugs Authority (FDA) with concern. For the purpose of cessation therapy, ENDS may be registered as a medication that requires a prescription only. For the purposes of cessation therapy, ENDS may be registered as a prescription-only drug, according to the FDA’s statement.
The FDA additionally warned that both the Public Health Act, 2012 (ACT 851) and Regulation 16 of the Tobacco Control Regulations 2016 (L.I. 2247) are invalid. Both of these regulations are broken by the sale and advertising of vapes and non-nicotine goods.
“Section 61 (2) states that it is illegal to sell, offer for sale, supply, or advertise a non-tobacco product or service that includes, on the product or in an advertisement for the product, any writing, picture, image, graphics, message, or other material that is frequently identified or associated with, likely to be associated with, or intended to be associated with, a tobacco product, brand, or manufacturer.”
Manufacturers, importers, distributors, and retailers were issued a warning by the FDA directing them to immediately take down all ENDS marketing from social media, billboards, and neon signs. They are also asked to avoid importing certain items.
As a result, manufacturers, importers, distributors, and retailers are urged to stop importing illegal tobacco products into the nation and to take down any ads on social media, on billboards, and on neon signs, among other places. A violation of the Public Health Act, 2012 (ACT 851) may result in penalties being applied if the aforementioned provisions and/or tobacco control legislation are not followed.
Vapes are electrical gadgets that allow users to breathe in vaporised liquid or solid substances through their mouths. These gadgets are frequently powered by batteries. Particularly electronic cigarettes generally have a tiny reservoir filled with a liquid nicotine solution that is heated and vaporised to create an aerosol mist that can be inhaled.